The European Centre for the Validation of Alternative Methods
(ECVAM), part of the Joint Research Centre (JRC), is seeking to
reduce animal testing as part of the upcoming EU directive that
aims to abolish animal testing in scientific...
Cytopia has received the green light to trial a promising new drug
that could prove effective in the fight against advanced solid
tumours. In animal studies, the drug candidate has already shown
efficacy in killing cancer cells in...
BioGenex announces the launch of the Xmatrx, a walk-away system
that automates molecular diagnostics and drug target identification
and validation. The system is specifically designed to enable drug
discovery companies to customise...
Malvern launches a new option for its range of Zetasizer Nano
particle characterisation systems, which enable scientists to
measure particle size at temperatures of up to 120C, extending the
range from the standard 90C.
Antares Pharma has announced that it has completed formulation and
preclinical activities for its first fast melt oral tablet
incorporating a nonsteroidal anti-inflammatory drug (NSAID) using
its Easy Tec fast melt technology.
Nanogen has been issued with a European patent, which relates to a
nanofabrication technology combining a manufacturing platform and
nanostructures that is set to broaden Nanogen's position in the
nanotechnology and nanomanufacturing...
Cambridge Major has announced that it has selected a new
low-temperature fluid, which has proven to be suitable for
single-fluid heating and cooling systems, making it appropriate to
meet the needs of the pharmaceutical industry.
Sigma, a division of Sigma-Aldrich Corporation has launched a new
offering of Custom AQUA Peptides for use with Protein-AQUA
Quantitative Proteomics, enabling important applications as
differential protein expression, biomarker quantification...
Millipore has introduced a single-use prefilter for clarification
steps in mammalian cell synthesis that continues the trend towards
increasing use of disposable technologies in the bioprocessing
environment, reports Phil Taylor.
An electronic nebuliser that matches a product formulation, which
was specifically developed to optimise this device's performance,
marks a new advance in the customisation of drug development and
represents a new aerosol delivery...
According to a new report, nanotechnology is set to play a major
part in drug delivery systems especially for tumour therapies. The
report cites nanoparticles as being particularly suited to curing
specific conditions such as cancer,...
Bentley Pharmaceuticals has entered into an agreement with Dong
Sung Pharmaceuticals for the development of an intranasal spray
formulation of insulin for the South Korean market with the view of
extending this deal into additional...